Dexamethasone Price — China Factory EXW 2026

Dexamethasone price Spec: China national standards

China EXW, VAT excluded

Newest China EXW USD 464,646.02 / MT · VAT excluded -185.8407 (-0.04%) as of 20200317

Newest Price 464,646.02

Price Date 20200317

Day's Change -185.84

Day's Range 464,646.02 - 464,460.18

Month's Change +185.84

Month's Range 464,646.02 - 464,831.86

Year's Change --

Year's Range --

The antitrust penalties mark a turning point, but buyers should note that dexamethasone sodium phosphate injection was included in China's ninth national volume-based procurement (...

Also known as (11B,16A)-9-FLUORO-11,17,21-TRIHYDROXY-16-METHYL-PREGNA-1,4-DIENE-3,20-DIONE, (11BETA,16ALPHA)-9-FLUORO-11,17,21-TRIHYDROXY-16-METHYLPREGNA-1,4-DIENE-3,20-DIONE, (8xi,11beta,16alpha)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione, 1,4-PREGNADIEN-9ALPHA-FLUORO-16ALPHA-METHYL-11BETA, 17ALPHA, 21-TRIOL 3,20-DIONE

Opinions

What caused dexamethasone injection prices to surge up to 282-fold in China during 2022-2023?

The antitrust penalties mark a turning point, but buyers should note that dexamethasone sodium phosphate injection was included in China's ninth national volume-based procurement (VBP) in November 2023. Post-VBP prices have dropped sharply—Xianju voluntarily cut prices by nearly 90%—yet still remain above earlier generic levels. For procurement managers, monitoring VBP award prices and supplier compliance is now more critical than tracking spot market quotes.

How concentrated is China's dexamethasone API supply and who are the key producers?

Beyond the top three, watch for capacity expansions by smaller registrants and new entrants. The antitrust case may push some hospitals and distributors to qualify alternative suppliers, which could gradually erode the incumbents' pricing power. Also note that dexamethasone is a basic medicine and Class A medical insurance drug—centralized procurement will continue to pressure margins, making API self-sufficiency a key competitive advantage for integrated players.

Will dexamethasone prices remain elevated after the antitrust fines and volume-based procurement?

For buyers, the practical takeaway is to lock in annual contracts through VBP or group purchasing mechanisms rather than relying on spot purchases. The price gap between VBP-awarded products and non-awarded ones can be substantial—sometimes several-fold. Also monitor raw material costs: dexamethasone API is derived from plant sterols like diosgenin, and any supply disruption in upstream extraction could still create temporary price spikes despite the antitrust environment.

Dexamethasone price context

What drives Dexamethasone prices

What caused dexamethasone injection prices to surge up to 282-fold in China during 2022-2023?: The antitrust penalties mark a turning point, but buyers should note that dexamethasone sodium phosphate injection was included in China's ninth national volume...

How concentrated is China's dexamethasone API supply and who are the key producers?: Beyond the top three, watch for capacity expansions by smaller registrants and new entrants. The antitrust case may push some hospitals and distributors to qual...

How we assess Dexamethasone price

China factory / mainstream market EXW quotes (VAT excluded where shown) - not a single global public index

Regional and specification detail so buyers can compare like-for-like grades

Landed cost figures from our calculator are planning estimates, not a customs ruling

Overview

Dexamethasone (CAS 50-02-2, C22H29FO5, MW 392.47) is a synthetic long-acting glucocorticoid receptor agonist appearing as a crystalline solid with a melting point of 262–264 °C and limited water solubility. It is widely used for its potent anti-inflammatory and immunosuppressive activity.

Pharmaceuticals: a core drug for treating severe COVID-19, multiple myeloma (in combination regimens such as IberDd), and inflammatory conditions.
Ophthalmology: combined with tobramycin in fixed-dose products for ocular infections and inflammation.
Research tools: conjugated to PEG-DBCO linkers for copper-free click chemistry targeting glycoproteins and glycans.
Pain management: formulated as dexamethasone palmitate for acute and subacute herpes zoster pain control in clinical trials.

China is a major global producer of dexamethasone API, with domestic supply led by Tianyao and Xianju Pharma. The market is mature and export-oriented, with recent demand supported by COVID-19 treatment protocols and ongoing clinical research into new indications and formulations.

Key domestic producers:
Tianyao Pharmaceutical – leading dexamethasone API producer.
Xianju Pharma – second-largest domestic API supplier.
Lianhuan Pharmaceutical – active in dexamethasone API production.

Properties

Name

Dexamethasone

(11B,16A)-9-FLUORO-11,17,21-TRIHYDROXY-16-METHYL-PREGNA-1,4-DIENE-3,20-DIONE

(11BETA,16ALPHA)-9-FLUORO-11,17,21-TRIHYDROXY-16-METHYLPREGNA-1,4-DIENE-3,20-DIONE

(8xi,11beta,16alpha)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione

1,4-PREGNADIEN-9ALPHA-FLUORO-16ALPHA-METHYL-11BETA, 17ALPHA, 21-TRIOL 3,20-DIONE

CAS Number

50-02-2

EINECS No.

200-003-9

Risk Codes

S36/37;S45;S36;S26;S22;S16

Safety Description

R43;R40;R36/37/38;R20/21/22;R42/43;R39/23/24/25;R23/24/25;R11

HS Code

2937220000

Cookie Preferences

Essential Cookies

Analytics Cookies

ChemPriceHub